Phase 3 Sarcomas Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Synovial Sarcomas
Takara Bio Inc.5 enrolled2 locationsNCT07174427
Recruiting
Phase 3
A Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas.
Metastatic soft tissue or bone sarcomas
ARIAD Pharmaceuticals, Inc.650 enrolled26 locationsACTRN12608000214336